UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (date of earliest event reported): December 3, 2019
CANNAE HOLDINGS, INC.
(Exact name of Registrant as Specified in its Charter)
| Delaware | | 1-38300 | | 82-1273460 |
(State or other jurisdiction of
incorporation) | | (Commission File Number) | | (IRS Employer Identification No.) |
1701 Village Center Circle
Las Vegas, Nevada 89134
(Addresses of principal executive offices)
(702) 323-7330
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | | Trading
Symbol | | Name of each exchange on which registered |
| Cannae Common Stock, $0.0001 par value | | CNNE | | New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Entry into Underwriting Agreement
On December 3, 2019, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with BofA Securities, Inc., as a representative of the underwriters named in Schedule 1 thereto (the “Underwriters”), pursuant to which the Company agreed to issue and sell 7,475,000 shares of common stock, par value $0.0001, of the Company (“Common Stock”) to the Underwriters at a public offering price of $33.00 per share (the “Offering”), which includes 975,000 shares of Common Stock sold pursuant to the full exercise of Underwriters’ option to purchase additional shares. Certain of the Company’s directors and officers and certain other related parties purchased, at the public offering price, approximately 84,200 shares of Common Stock. The Offering closed on December 6, 2019. The net proceeds to the Company from the Offering were approximately $236.2 million, after deducting the underwriting discount and estimated offering expenses payable by the Company. The Company intends to use the net proceeds of the Offering to fund future acquisitions and for working capital and general corporate purposes.
The Offering was made pursuant to a prospectus supplement, dated December 3, 2019, and the prospectus, dated November 27, 2019, included in the Company’s registration statement on Form S-3 (File No. 333-235303), which was initially filed with the Securities and Exchange Commission on November 27, 2019.
The Underwriting Agreement contains customary representations, warranties and covenants and includes the terms and conditions for the sale of the shares of Common Stock by the Company to the Underwriters, indemnification and contribution obligations and other terms and conditions customary in agreements of this type. The Company and certain of its directors and executive officers also agreed not to sell or transfer any Common Stock for 60 days after December 3, 2019 without first obtaining the written consent of BofA Securities, Inc. as a representative on behalf of the Underwriters, subject to certain exceptions as described in the prospectus supplement.
A copy of the Underwriting Agreement is filed as Exhibit 1.1 hereto. The above description is qualified in its entirety by reference to such exhibit.
| Item 9.01 | Financial Statements and Exhibits |
(d) Exhibits
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | Cannae Holdings, Inc. |
| | |
| Date: December 6, 2019 | By: | /s/ Michael L. Gravelle |
| | | Name: | Michael L. Gravelle |
| | | Title: | Executive Vice President, General Counsel, and Corporate Secretary |
